Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB) Source: Eur Respir J 2006; 28: Suppl. 50, 395s Year: 2006
Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019
Haptoglobin (Hp) phenotypes and smoking history in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 260s Year: 2002
Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 586s Year: 2005
Circulating auto antibodies in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008
IgG immunoglobulin levels and the frequency of respiratory infections in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 543s Year: 2002
Heredity and smoking factor in relatives patients with chronic obstructive pulmonary disease - chronic obstructive bronchitis (I) and chronic nonobstructive bronchitis (II) Source: Eur Respir J 2001; 18: Suppl. 33, 214s Year: 2001
Prevalence of chronic obstructive pulmonary disease (COPD) in Greece Source: Eur Respir J 2002; 20: Suppl. 38, 122s Year: 2002
Prediction of vascular-platelet hemostasis disorders in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Investigations of COPD Year: 2020
Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 89s Year: 2002
Pathogenic therapy of patients with chronic obstructive pulmonary diseases (COPD) Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007
Prevalence of chronic obstructive pulmonary disease (COPD) in primary care Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008
Low circulating CD34+ cells in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005
Periostin levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018
The ability to taste the bitter of phenylthiocarbamide (PTC) in patients with chronic obstructive pulmonary disease (COPD) and chronic non-obstructive bronchitis (CNOB) Source: Eur Respir J 2002; 20: Suppl. 38, 260s Year: 2002
Community-acquired pneumonia (CAP) in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009
Can chronic obstructive lung disease (COPD) criteria be used to manage bronchiectasis (BR) and obliterative bronchiolitis (OB) in children surviving severe lung infection? Source: Eur Respir J 2001; 18: Suppl. 33, 172s Year: 2001
Study on the relation between serum complement (C3, C4) levels and acute exacerbations in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008
Iron deficiency as a novel biomarker of functional impairment in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011
The state of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007